2 pieces, congestion
2 pieces, foci of hepatocyte necrosis and ballooning degeneration
2 pieces, diffuse macro and microvesucular steatosis, nodular regenerative changes
2 pieces; central vascular congestion
2 pieces, includes capsule (target is 1 cm below capsule), few collections of lymphocytes, often in portal tracts
2 pieces, includes capsule (target is 1 cm below capsule), micro and macrovesicular steatosis
2 pieces; moderate central vascular congestion; mild macrovesicular steatosis; thin capsule present
2 pieces, congested, includes capsule (target is 1 cm below capsule), chronic inflammation
2 pieces, moderate congestion, minimal steatosis
2 pieces, mild to moderate steatosis
2 pieces; capsule present on one piece
2 pieces, mild steatosis
2 pieces, moderate congestion; no significant steatosis
2 pieces, mild macrovesicular steatosis, passive congestion
2 pieces moderate passive congestion
2 pieces, no major abnormalities
2 pieces, mild steatosis and passive congestion
2 pieces moderate macro and microvesicular steatosis, moderate congestion, early bridging fibrosis
2 pieces; 20% macrovesicular steatosis
2 pieces, ~ 5% macrovesicular fat.
3 pieces; moderate macrovesicular steatosis
2 pieces; 5% macrovesicular steatosis
2 pieces, diffuse microvesicular steatosis, mild-moderate  fibrosis
2 pieces; mild central degeneration
2 pieces, mild macro and microvesicular steatosis
3 pieces; accentuation of portal tracts with fibrosis and  congestion
2 pieces, minimal steatosis
2 pieces; 50% macrosteatosis
2 pieces; some congestion and steatosis
2 pieces; some congestion and portal chronic inflammation
2 pieces; steatosis, bridging fibrosis, and chronic inflammation (?Nonalcoholic steatohepatitis)
2 pieces; macrovesicular steatosis, Mallory hyaline, pericellular and perivenular fibrosis, and rare acute inflammation c/w alcohol use
2 pieces; includes portion of capsule (target is 1 cm below capsule), mild steatosis, passive congestion, focal portal chronic inflammation
2 pieces; severe microvescicular and macrovesicular (predominant) steatosis, mild fibrosis
2 pieces; moderate macrovesicular steatosis with some fibrosis
2 pieces; includes capsule (target is 1cm below capsule), mild steatosis and some portal chronic inflammation
2 pieces; congestion  and accentuation of portal triads with fibrosis and mild lymphocytic infiltrate
2 pieces, diffuse macrovesicular steatosis involves >80% parenchyma
2 pieces, micro (mainly) and macrovesicular steatosis involves ~70% parenchyma
2 pieces; congestion
2 fragmented pieces; 20% of each consists of large vessels & nerves [outlined]
2 pieces; congestion and accentuation of portal triads
2 pieces, minimal steatosis, mulitple bile duct hamartomata (Meyenberg Complex) noted.
2 pieces
2 pieces; periportal fibrosis with chronic inflammation and early bridging fibrosis
2 pieces
2 pieces, no abnormalities
2 pieces; 10% macrovesicular steatosis
2 pieces, mild congestion, mild chronic hepatitis.  No significant steatosis.
2 pieces moderate congestion; no significant steatosis or hepatitis noted
2 pieces; 80% macrovesicular steatosis, portal inflammation and bridging fibrosis  consistent with nonalcoholic steatohepatitis
2 pieces; moderate centrilobular congestion
2 pieces, moderate passive congestion
2 pieces, mild congestion; ~10% macrovesicular parenchymal fat
2 pieces, moderate-severe subacute chronic congestion
2 pieces, minimal steatosis
2 pieces
6 pieces, minimal congestion, no steatosis
2 pieces, no steatosis, minimal congestion
2 pieces, no steatosis
11.2x 8.3mm.  About 10% macrovesicular steatosis.
2 pieces ~8x7mm; mild steatosis
2 pieces,~ 6x8 mm; central sinusoidal dilatation; focal fragmentation
2   ~9x7.5mm aliquots, patchy mixed micro-and macro-vesicular steatosis,  ~25%
2  ~7.5x7.5mm aliquots.  Severe bridging fibrosis/early cirrhosis with steatotis and chronic hepatitis.
2   ~9.5x8mm aliquots.  Macrovesicular steatohepatitis (~20% fat), bridging fibrosis focally approaching early cirrhosis; moderate chronic inflammation
2 ~8x7mm aliquots. Focal macrovesicular steatosis involves !0% of parenchyma
2    ~7.5x7.5mm aliquots, diffuse macrovesicular steatosis and chronic hepatitis with bridging fibrosis
2 pieces ~9x8mm; central pallor; no fibrosis or inflammation
2 pieces 10x7&8x6.7 mm;   good preservation, no lesions
2 aliquots,   ~8x7mm.  Moderate congestion
2 pieces, 8x7 & 7x6 mm; no congestion
2 aliquots,  ~9x9mm, diffuse macrovesicular steatosis involves 80+% of parenchyma
2 aliquots,  ~8x6mm, moderate congestion
2 pieces, 9x7 & 7x7 mm;
2 pieces, 7x6 & 7x6 mm; no lesions
2 aliquots,  ~7x6mm.  Moderate congestion, focal microvesicular steatosis involves  ~10-15% of parenchyma
2 aliquots,  ~7x6mm.  Fairly well preserved, minimal fat
2 pieces 10x7 & 8x7 mm; large area of hemorrhage in each: 10 and 25% of specimen
2 pieces 8x5 & 7x7 mm; not congested
2 pieces 11x8 & 10x8 mm; moderate macrovesicular steatosis; mild microvesicular steatosis
2 pieces  ~10x8mm.  Moderate congestion, moderately autolyzed
2 pieces 8x7 & 8x7 mm; large vessel runs through one piece; central congestion
2 pieces   ~8x7mm.  Minimal steatosis
2 pieces, 9x7 & 8x7 mm;  moderate macrovesicular steatosis; no fibrosis
2 pieces, 8x8 & 8x7mm; no steatosis, no fibrosis
2 pieces, 8x7 & 6x6mm; no fat, fibrosis  or excess congestion
2 pieces, 8x7.5 & 7x7mm; moderate congestion; some portal fibrosis
2 pieces   ~9x8mm.  10% macrovesicular steatosis
2 pieces,  ~9x9mm. Diffuse macrovesicular steatosis involves 90+ % of specimens, which are well - preserved
2 pieces  ~7x7mm, 30% macrovesicular steatosis, moderate passive congestion
2 pieces, 9x8 & 10x9mm; minimal fat/congestion
2 pieces, 8x7 & 7.5x7mm; no significant fat
2 pieces, 6.5x6 & 6x6mm; no lesions
2 pieces, 11x9 & 12x9mm; giant cell granulomas (history of sarcoid); capsule present up to 0.4mm thick, specimen should be sampled below capsule
2 pieces, 7x7 & 8x8mm; no lesions
2 pieces, 9x8 & 8.5x8mm; diffuse macrovesicular steatosis with early cirrohsis; rep steatotic areas delineated
2 pieces, 8x7 & 8x8mm; 20% macrovesicular steatosis
2 pieces, 9x7 & 8x8mm; 70-80% macrovesicular steatosis with patchy bridging fibrosis
2 pieces. 9x8 & 10x8mm; minimal steatosis
2 pieces. 13x9 & 13x10mm; 70% small droplet variant of macrovesicular steatosis.
2 pieces, 10x10 & 11x10mm; mild-moderate macrovesicular steatosis involving ~30-40% of parenchyma
2 pieces, 12x10 & 11x11mm; marked central and mid-zonal  coagulative necrosis necrosis, shock vs toxic damage by drugs
2 pieces, 12x5 and 10x8mm; diffuse macrovesciular steatosis involves ~80% of parenchyma
2 pieces, 8x8 and 8x7mm;
2 pieces, minimal steatosis, moderate autolysis
2 pieces, diffuse macrovesicular steatosis involves ~ 50% of parenchyma
2 pieces. Extensive central passive  congestion and hemorrhage. Large vessels and stroma occupy 10% and 20%.
2 pieces; diffuse macrovesicular steatosis involving about %60 of the liver parenchyma, few collections of chronic inflammatory cells
2 pieces; diffuse severe microvesicular and macrovesicular steatosis (~80%).
2 pieces.
2 pieces, mild steatosis and focal mild portal chronic inflammation
2 pieces, extensive congestion, necrosis, 25% of parenchyma preserved
2 pieces, steatohepatitis with bridging fibrosis and incomplete cirrhosis
2 pieces, mild macrovesicular steatosis (~10-20%)
2 pieces, moderate congestion, minimal steatosis
2 pieces, mild congestion, moderate autolysis.  No significant steatosis
2 pieces, severe passive congestion, mild steatosis (~10%)
2 pieces, steatosis, sections include capsule (should be 1cm below capsule)